WELLS FARGO & COMPANY/MN - MATINAS BIOPHARMA HLDGS INC ownership

MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 48 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of MATINAS BIOPHARMA HLDGS INC
ValueSharesWeighting
Q3 2023$65,866
-67.7%
506,660
-10.6%
0.00%
Q2 2023$203,958
+6500.6%
566,550
+8516.7%
0.00%
Q1 2023$3,090
-5.7%
6,575
+0.4%
0.00%
Q4 2022$3,277
-74.8%
6,552
-68.7%
0.00%
Q3 2022$13,000
-18.8%
20,942
+0.7%
0.00%
Q2 2022$16,000
-5.9%
20,806
+0.5%
0.00%
Q1 2022$17,000
-19.0%
20,698
+0.0%
0.00%
Q4 2021$21,000
-19.2%
20,694
+5.1%
0.00%
Q3 2021$26,000
+766.7%
19,685
+542.5%
0.00%
Q2 2021$3,000
-85.0%
3,064
-83.7%
0.00%
Q1 2021$20,000
-95.3%
18,748
-94.0%
0.00%
Q4 2020$422,000
+47.6%
310,502
-16.9%
0.00%
Q3 2020$286,000
-34.6%
373,557
-34.0%
0.00%
Q2 2020$437,000
+48.1%
566,152
+15.2%
0.00%
Q1 2020$295,000
-65.0%
491,498
+32.2%
0.00%
Q4 2019$843,000
+497.9%
371,739
+67.8%
0.00%
Q3 2019$141,000
+60.2%
221,578
+114.6%
0.00%
Q2 2019$88,000
+214.3%
103,274
+297.2%
0.00%
Q1 2019$28,000
+133.3%
26,000
+23.8%
0.00%
Q4 2018$12,000
-36.8%
21,000
-1.1%
0.00%
Q3 2018$19,00021,224
+1634.0%
0.00%
Q2 2018$0
-100.0%
1,224
-98.5%
0.00%
Q1 2018$64,000
-28.9%
83,562
+7.5%
0.00%
Q4 2017$90,000
+1700.0%
77,753
+2013.4%
0.00%
Q3 2017$5,0003,6790.00%
Other shareholders
MATINAS BIOPHARMA HLDGS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 1,429,532$1,944,0000.61%
Boxer Capital, LLC 11,478,634$15,611,0000.50%
Vivo Capital, LLC 6,451,612$8,774,0000.39%
Philadelphia Financial Management of San Francisco, LLC 740,861$1,008,0000.26%
DCF Advisers, LLC 305,299$415,0000.17%
Main Street Financial Solutions, LLC 400,826$545,0000.11%
Platform Technology Partners 158,660$216,0000.10%
STALEY CAPITAL ADVISERS INC 600,000$816,0000.05%
MONECO Advisors, LLC 50,000$81,0000.04%
CCG WEALTH MANAGEMENT, LLC 30,000$41,0000.04%
View complete list of MATINAS BIOPHARMA HLDGS INC shareholders